Guest guest Posted August 11, 2005 Report Share Posted August 11, 2005 http://tinyurl.com/bveqx Streptococcal Infection Author(s): Bashir Gaash Streptococci were first demonstrated in patients with erysipelas by Billroth in 1874, and isolated in 1883 by Fehleisen, but it was Rosenbach who, in 1884, applied the designation to the group. The name `streptococcus' is derived from the Greek `streptos' signifying a chain formed of links or a necklace of beads; `coccus' meaning a berry. The organisms may occur in pairs or in chains of varying length. There are two main types: haemolytic & non-haemolytic. The haemolytic ones are further divided on whether they lead to alpha, beta or gamma hemolysis. In beta-haemolysis, a colony of organisms grown on blood agar is surrounded by a clear zone, 2-4 mm in diameter, within which the RBC are completely lysed. Strep. pyogenes and other streptococci that show a similar phenotype are called â-haemolytic streptococci. They are pathogenic in man. In contrast, species that are typically part of the normal throat flora are either non-haemolytic, or they produce á-haemolysis, characterized by a zone of incomplete, often greenish clearing around colonies grown on blood agar. The â-hemolytic streptococci grow poorly on ordinary nutrient agar but more readily on blood agar: the zones of beta-hemolysis are fully developed after 18 hours' growth and very little enlargement occurs thereafter. The colonies do not exceed 1 mm in size. Although the organisms grow both aerobically & anaerobically, â-haemolysis develops more readily anaerobically. Although the growth is possible over a wider range of temperatures, the optimum temperature is 37°C. Virulence Factors & Toxins a) Extracellular products: Haemolysins (Streptolysins): Two types of haemolysins, O & S, which are at peak 8 hours after incubation at 37°C, are produced in broth culture. The O-haemolysin is readily oxidized (derives its name from oxygen-liability) while the S-hemolysin is oxygen-stable, (derives its S from being produced by streptococci growing in the presence of serum). The former is produced by all streptococci while as the latter is only produced by group A, C & G. Streptolysin O & S are the proteins responsible for beta-haemolysis. They lyse RBC & WBC by making holes in their cell membrane. Streptolysins are toxic to the body; streptolysin O is antigenic and leads to production of antibodies (antistreptolysin O) while streptolysin S is either non-antigenic or too weakly antigenic. Antistreptolysin O (ASO) is a true antibody which rises as a result of streptococcal infection. That is why practitioners want to know its titre. It is an exceedingly useful indicator of recent streptococcal infection. Anti-streptolysin `O' is toxic to a variety of cells and cell fractions including polymorphonuclear leukocytes, platelets, lysosomes etc. Previously it was thought that a separate haemolysin , leucocidin, destroyed white blood cells. Now we know that it is identical with streptolysin O. Several extracellular factors serve to facilitate liquefaction of pus and the spreading of streptococci through tissue planes. Four antigenically different DNAses (A, B, C & D) participate in the degradation of deoxyribonucleic acid. Previously, de-oxyribonuclease used to be called Streptodornase. Streptokinase, another toxic product of GAS, leads to dissolution of clots by catalyzing the conversion of plasminogen into plasmin. Proteinase is another factor liberated by GAS. A spreading factor, hyaluronidase, is also found in streptococcal filtrates. These enzymes degrade the tissue and enhance the spread of infection. The tissue destruction in turn leads to inflammatory response which leads to various symptoms and signs. Streptococcal pyrogenic exotoxins (SPEs) are a family of genetically similar exotoxins that cause severe streptococcal disease unrelated to strep throat. These diseases include scarlet fever, streptococcal toxic shock syndrome, and `flesh eating' necrotizing fasciitis. These exotoxins are superantigens, which can lead to massive activation of T cells. The resulting uncontrolled release of cytokines is responsible for the seriousness of these infections. Erythrogenic (Dick) toxin belongs to this group. It is an SPE released from the infection site which enters the bloodstream, circulates throughout the body and leads to a redness of skin and whitish coating of the tongue. Antibodies to five of extracellular products are used in the serodiagnosis of streptococcal infection. These are ASO, anti-DNase, antihyaluronidase, antinicotinamine adenine dinucleotidase, and antistreptokinase. Somatic Antigens: In addition to elaborating various toxins, Group A streptococci (GAS) posses different somatic protein antigens, which enable GAS to be further divided. This typing is of great value in the study of outbreaks of streptococcal infection. M protein causes the degradation of complement component C3b, an opsonin that would otherwise promote phagocytosis of the bacteria. M protein is essential for the virulence of GAS, because antibody to it prevents infection from occurring. Organisms which do not have M protein are avirulent. More than 90 different kinds of M protein exist and, unfortunately, antibody to one type does not prevent infection by a strain that has another kind of M protein. Another protein antigen closely related to the M protein is the serum opacity-factor (OF). This is itself antigenic and type- specfic; it is useful as an epidemiological marker in typifying GAS when they are not identifiable on the basis of M antigen. It has been found that immune response to M-protein is generally weaker after pharyngeal infection with OF-positive than with OF-negative strains. Protein F of the cell wall mediates attachments of GAS to the throat by adhering to a protein found on the surface of the epitheloid cells. Another cell wall constituent, lipoteichoic acid, plays a similar role in the first step in colonization ie adherence of GAS to fibronectin on the surface of human epithelial cells. Protein G of the bacterium binds to the Fc segment of immunoglobulin G. The effect is to prevent phagocytosis mediated by specific antibody against the bacterium. There are other multifunctional surface proteins which have the ability to bind to host proteins, including immunonoglobulin G & A. C5a peptidase is an enzyme released by GAS, which destroys the C5a component of the complement system, which normally attracts phagocytes to the site of a bacterial infection. This cell-bound peptidase cleaves the C5a component of the complement and inhibits neutrophil chemotaxis. Both, M antigen and the capsule, which contains mucopolysaccharide hyaluronic acid, are related to the virulence of the strain. M protein is the major somatic virulence factor, while hyaluronic acid capsule is an accessory virulence factor. Both retard phagocytosis of the microorganism by polymorphonuclear leukocytes's and strains containing this, being resistant to phagocytosis, multiply rapidly in body and initiate disease. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.